ERICA HESSIFER: Open Payments
NPI 1801262902 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,939 in 167 payments from 17 companies in 2025. Trend: 2023 $2,851 · 2024 $3,024 · 2025 $2,939
Food & beverage: $2,928Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $421 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $399 |
| Neurocrine BioSciences, Inc. | 13 | $349 |
| Otsuka America Pharmaceutical, Inc. | 19 | $290 |
| Vanda Pharmaceuticals Inc. | 10 | $195 |
| Alkermes, Inc. | 14 | $193 |
| Corium, LLC | 11 | $191 |
| Janssen Pharmaceuticals, Inc | 4 | $189 |
| Teva Pharmaceuticals USA, Inc. | 15 | $184 |
| Axsome Therapeutics, Inc. | 14 | $162 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, ARISTADA, Azstarys, Auvelity, FANAPT.
Industry payments across LA — which companies pay providers there.
